Zymogenetics (ZGEN) volatility flat; Bristol-Meyers Squibb (BMY) purchasing ZGEN for $735M

September 8, 2010 8:24 AM EDT Send to a Friend
Bristol-Myers Squibb (NYSE: BMY) and ZymoGenetics (Nasdaq: ZGEN) announced that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login